Paper31746940
Renal denervation: bleak past, brighter future.
Rayner B. Cardiovasc J Afr, 2019. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Renal denervation: bleak past, brighter future. Papers, record 31746940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31746940
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics2
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney | Major topic |
| Denervation |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 31746943 | Renal denervation: dark past, bright future? | https://conductscience.org/library/papers/31746943 |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26724178 | Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. | Lancet | 2016 | https://conductscience.org/library/papers/26724178 | PubMed |
| 2 | 29803590 | Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. | Lancet | 2018 | https://conductscience.org/library/papers/29803590 | PubMed |
| 3 | 24210779 | Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. | Lancet | 2014 | https://conductscience.org/library/papers/24210779 | PubMed |
| 4 | 31746943 | Renal denervation: dark past, bright future? | Cardiovasc J Afr | 2019 | https://conductscience.org/library/papers/31746943 | PubMed |
| 5 | 24678939 | A controlled trial of renal denervation for resistant hypertension. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24678939 | PubMed |
| 6 | 29803589 | Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. | Lancet | 2018 | https://conductscience.org/library/papers/29803589 | PubMed |
| 7 | 24898552 | Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial. | Eur Heart J | 2014 | https://conductscience.org/library/papers/24898552 | PubMed |
| 8 | 30015759 | European Society of Hypertension position paper on renal denervation 2018. | J Hypertens | 2018 | https://conductscience.org/library/papers/30015759 | PubMed |
| 9 | 25629715 | South African hypertension practice guideline 2014. | Cardiovasc J Afr | 2014 | https://conductscience.org/library/papers/25629715 | PubMed |
| 10 | 29133354 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | Hypertension | 2018 | https://conductscience.org/library/papers/29133354 | PubMed |
| 11 | 26693818 | Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study. | Hypertension | 2016 | https://conductscience.org/library/papers/26693818 | PubMed |
| 12 | 19272490 | Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. | Am J Med | 2009 | https://conductscience.org/library/papers/19272490 | PubMed |
| 13 | 28859944 | Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. | Lancet | 2017 | https://conductscience.org/library/papers/28859944 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31746940
GET https://conductscience.org/api/papers/v1/31746940/authors